로딩 중…
지수 로딩 중…
Korro Bio, Inc.
KRRO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$12.99+17.56%
2026-06-18
Price Chart
Korro Bio, Inc.+4.25%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $187M |
| Revenue | $4M |
| Net Income | $-113M |
| Total Assets | $184M |
| Net Assets | $120M |
| Value | |
| P/B | 1.57x |
| P/S | 48.76x |
| FCF Yield | -37.69% |
| Profitability | |
| ROE | -94.87% |
| ROA | -61.81% |
| Op. Margin | -2154.03% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 53.49% |
| Total Debt | $43M |
| FCF | $-71M |
| Cash | $62M |
| Current Ratio | 8.13x |
| Performance | |
| 1Y Return | 4.25% |
| 1M Return | 41.97% |
| From 52W High | -76.76% |
| 1Y MDD | -89.72% |
| Trading | |
| Volume | 595,910 shares |
| Trading Value | $7M |
| Per Share | |
| EPS | $-12.48 |
| BPS | $5.47 |